fda safety communication semaglutide naion 2025 Ozempic Blindness Lawsuit [2026 Guide]

The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and

23.65

★★★★☆4.8 (126)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

26.26

★★★★★4.9 (98)

Thinking about buying GLP-1 and other products labeled “for research purposes” or “not for human consumption”? Think again. These products have not been reviewed by FDA for safety, effectiveness or quality and

29.89

★★★★★5.0 (157)

Live Updates on Semaglutide's Current and Future Uses

25.31

★★★★★4.7 (84)

Ozempic (Semaglutide) Receives FDA Supplemental Efficacy Approval

25.97

★★★★★4.9 (203)

The obesity drug semaglutide (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of FDA data showed. Added

21.18

★★★★★5.0 (176)

Ozempic Eye Problems Explained: Vision Loss & Blurred Vision

29.78

★★★★★4.8 (132)